Acute hepatocellular drug-induced liver injury probably caused by doxazosin

Jiménez-Sánchez, Javier; Serrano-Díaz, Lidia; Martínez-Crespo, Juan-José

RICSMUR Principal
→
02. Servicio Murciano de Salud (SMS)
→
02.07. Área de Salud VII Murcia Este
→
02.07.01. Investigación y comunicación científica
→
Ver ítem

dc.contributor.author	Jiménez-Sánchez, Javier
dc.contributor.author	Serrano-Díaz, Lidia
dc.contributor.author	Martínez-Crespo, Juan-José
dc.date.accessioned	2025-12-03T11:11:33Z
dc.date.available	2025-12-03T11:11:33Z
dc.date.issued	2021
dc.identifier.citation	Jiménez Sánchez J, Serrano Díaz L, Martínez Crespo JJ. Acute hepatocellular drug-induced liver injury probably caused by Doxazosin. Rev Esp Enferm Dig [Internet]. 2020 [citado 1 de diciembre de 2025]; Disponible en: https://online.reed.es/fichaArticulo.aspx?iarf=732793155343-589166824253
dc.identifier.issn	1130-0108
dc.identifier.uri	https://sms.carm.es/ricsmur/handle/123456789/22930
dc.description.abstract	Drug-induced liver injury (DILI) is a diagnostic challenge, due to the hepatotoxic potential of drugs, herbs and dietary supplements, the variety of pathological phenotypes and the absence of specific biomarkers.
dc.language.iso	eng
dc.publisher	ARAN Ediciones S.A.
dc.rights	Atribución/Reconocimiento-NoComercial-SinDerivados 4.0 Internacional
dc.rights.uri	https://creativecommons.org/licenses/by-nc-nd/4.0	*
dc.subject.mesh	Carcinoma, Hepatocellular
dc.subject.mesh	Chemical and Drug Induced Liver Injury/etiology
dc.subject.mesh	Dietary Supplements
dc.subject.mesh	Doxazosin
dc.subject.mesh	Humans
dc.subject.mesh	Liver
dc.subject.mesh	Liver Neoplasms
dc.title	Acute hepatocellular drug-induced liver injury probably caused by doxazosin
dc.type	info:eu-repo/semantics/article
dc.identifier.pmid	33213177
dc.relation.publisherversion	https://online.reed.es/fichaArticulo.aspx?iarf=732793155343-589166824253
dc.identifier.doi	10.17235/reed.2020.7268/2020
dc.journal.title	Revista Española de Enfermedades Digestivas
dc.identifier.essn	2340-4167